By Robert L. Roy, IPS
Building a facility to produce vaccines is among the most challenging endeavors an organization can undertake. Timelines are long, budgets are likely to be tight, and the technology is ever-changing.
IPS designs up to a dozen such facilities every year, leveraging a blend of technical, healthcare, and architectural talent to create pharmaceutically elegant facility designs that meet customers’ production capacity, project timeline, and project budget objectives.
Here, we examine challenges faced by pharmaceutical companies when designing a facility to produce vaccines — be it an active pharmaceutical ingredient (API) manufacturing facility or an aseptic fill/finish facility. We also discuss how IPS can help customers overcome those challenges.